Pharyngeal Electrical Stimulation versus None for Post-Stroke Dysphagia: Rationale, Design, and Protocol for the Parallel Group Superiority Pharyngeal Electrical Stimulation for Acute Stroke Dysphagia Trial (PhEAST) (ISRCTN98886991)
Cerebrovascular Diseases Extra · 21.07.2026 · 16 (1) · 248-254
DOI: 10.1159/000553643 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 21.07.2026. Verfasst von Jacqueline K Benfield und 28 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Trials Unit, Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Deglutition Disorders, Electric Stimulation Therapy, Ischemic Stroke, Pharynx. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Dysphagie, Schlaganfall
Abstract (Originalsprache)
Introduction
Acute ischaemic stroke and primary intracerebral haemorrhage are complicated by oropharyngeal dysphagia in more than 50% of patients. Currently, there are no definitive treatments for post-stroke dysphagia (PSD). Pharyngeal electrical stimulation (PES) can drive long-term beneficial changes in the cortical control of swallowing with functionally relevant reorganisation of the swallowing cortex correlating with reduced dysphagia.
Methods
The pharyngeal electrical stimulation for acute stroke dysphagia trial (PhEAST) is an international prospective randomised open-label blinded-endpoint parallel-group phase 4 superiority effectiveness trial. A total of 638 patients with PSD and dependency on nasogastric tube feeding are being recruited within 2–31 days of ictus. Participants are recruited from the UK and Austria and randomised to 6 days of optimised PES (given for 10 min each day) vs. no PES on top of standard care. The primary outcome is the dysphagia severity rating scale, an assessment of swallowing impairment, measured locally on day 14 and centrally at day 90 by trained observers masked to treatment and analysed using repeated measures regression analysis. Secondary outcomes include: functional oral intake scale, feeding status scale, international dysphagia diet standardisation initiative scale, presence of a feeding tube, pneumonia, antibiotic use, health-related quality of life, dependency, disability, frailty, mood, cognition, global impact and health economics at days 14, 90, 180, and 365. Safety measures include death and serious adverse events.
Conclusion
PhEAST has recruited more than 574 participants from 45 hospitals in the UK and Austria; recruitment will be complete at the end of October 2026. The attached Supplement summarises the protocol and follows the EQUATOR SPIRIT guideline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stroke Trials Unit, Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
- Acute Speech and Language Therapy Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK.
- Stroke, Department of Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Stroke, University Hospitals of Derby and Burton, Derby, UK.
- Department of Neurology and Neurorehabilitation, Klinikum Osnabrueck-Academic Teaching Hospital of the University Muenster, Osnabrueck, Germany.
Zitieren
APA
Benfield, J. K., Everton, L. F., Woodhouse, L. J., Mhlanga, I. I., Latulipe, C., Skinner, C. J. C., Buck, A., Squires, G., Roadevin, C., Fiddy-Kent, R., Munsif, N., Wilkinson, G., Cadman, K. M., Hamilton, T., Smith, P., Appleton, J. P., Dziewas, R., Iversen, H. K., Krishnan, K., …, & Bath, P. M. (2026). Pharyngeal Electrical Stimulation versus None for Post-Stroke Dysphagia: Rationale, Design, and Protocol for the Parallel Group Superiority Pharyngeal Electrical Stimulation for Acute Stroke Dysphagia Trial (PhEAST) (ISRCTN98886991). Cerebrovascular Diseases Extra, 16(1), 248-254. https://doi.org/10.1159/000553643
Vancouver
Benfield JK, Everton LF, Woodhouse LJ, Mhlanga II, Latulipe C, Skinner CJC, et al. Pharyngeal Electrical Stimulation versus None for Post-Stroke Dysphagia: Rationale, Design, and Protocol for the Parallel Group Superiority Pharyngeal Electrical Stimulation for Acute Stroke Dysphagia Trial (PhEAST) (ISRCTN98886991). Cerebrovascular Diseases Extra. 2026;16(1):248-254. doi:10.1159/000553643
BibTeX
@article{Benfield2026,
author = {Benfield, Jacqueline K and Everton, Lisa F and Woodhouse, Lisa J and Mhlanga, Iris Isheanesu and Latulipe, Corinne and Skinner, Cameron J C and Buck, Amanda and Squires, Gemma and Roadevin, Cristina and Fiddy-Kent, Roxanne and Munsif, Nazrana and Wilkinson, Gwenllian and Cadman, Kennedy M and Hamilton, Tiffany and Smith, Patrick and Appleton, Jason P and Dziewas, Rainer and Iversen, Helle K and Krishnan, Kailash and Matz, Karl and Mistry, Satish and Smith, Craig J and Steiner, Thorsten and Sprigg, Nikola and Montgomery, Alan A and James, Marilyn and England, Timothy J and Hamdy, Shaheen and Bath, Philip M},
title = {Pharyngeal Electrical Stimulation versus None for Post-Stroke Dysphagia: Rationale, Design, and Protocol for the Parallel Group Superiority Pharyngeal Electrical Stimulation for Acute Stroke Dysphagia Trial (PhEAST) (ISRCTN98886991)},
journal = {Cerebrovascular Diseases Extra},
year = {2026},
volume = {16},
number = {1},
pages = {248--254},
doi = {10.1159/000553643}
}
EUVIMED